Mark Kristiansen
Genomics (United Kingdom)(GB)University College London(GB)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Alzheimer's disease research and treatments, SARS-CoV-2 and COVID-19 Research, Epigenetics and DNA Methylation, Amyotrophic Lateral Sclerosis Research
Most-Cited Works
- → Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes(2020)273 cited
- → Disease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome(2007)255 cited
- → Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity(2020)227 cited
- → Proteomic Profiling of Plasma in Huntington's Disease Reveals Neuroinflammatory Activation and Biomarker Candidates(2007)225 cited
- → Disease-related Prion Protein Forms Aggresomes in Neuronal Cells Leading to Caspase Activation and Apoptosis(2005)145 cited
- → Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood(2007)140 cited
- → Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry(2011)116 cited
- → Programmed cell death during neuronal development: the sympathetic neuron model(2014)113 cited
- → DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study(2019)100 cited
- → Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation(2007)78 cited